Posted on Leave a comment

Titan Receives Notice of Allowance for Probuphine Patent Application in the Treatment of Opiate Addiction (Business Wire via Yahoo! Finance)

More info…
SOUTH SAN FRANCISCO, Calif.—-Titan Pharmaceuticals, Inc today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for Titans United States patent application directed to the use of Probuphine for the treatment of opiate addiction.

opiate detox

Leave a Reply

Your email address will not be published.